Fresenius Kabi USA LLC:企業の戦略的SWOT分析

◆英語タイトル:Fresenius Kabi USA LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C15789
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Kabi USA LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable drugs and delivery systems, advanced transfusion medicine, cell therapy, infusion, and clinical nutrition technologies. Its products include oncology, anesthesia, analgesia, anti-infectives, parenteral nutrition, iv solutions and other critical care therapies. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Kabi USA LLC – Key Facts
Fresenius Kabi USA LLC – Key Employees
Fresenius Kabi USA LLC – Key Employee Biographies
Fresenius Kabi USA LLC – Major Products and Services
Fresenius Kabi USA LLC – History
Fresenius Kabi USA LLC – Company Statement
Fresenius Kabi USA LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Kabi USA LLC – Business Description
Fresenius Kabi USA LLC – SWOT Analysis
SWOT Analysis – Overview
Fresenius Kabi USA LLC – Strengths
Fresenius Kabi USA LLC – Weaknesses
Fresenius Kabi USA LLC – Opportunities
Fresenius Kabi USA LLC – Threats
Fresenius Kabi USA LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Fresenius Kabi USA LLC, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Kabi USA LLC, Key Facts
Fresenius Kabi USA LLC, Key Employees
Fresenius Kabi USA LLC, Key Employee Biographies
Fresenius Kabi USA LLC, Major Products and Services
Fresenius Kabi USA LLC, History
Fresenius Kabi USA LLC, Other Locations
Fresenius Kabi USA LLC, Subsidiaries
Fresenius Kabi USA LLC, Key Competitors
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Fresenius Kabi USA LLC, Recent Deals Summary

List of Figures
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Fresenius Kabi USA LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wawa Inc:企業の戦略・SWOT・財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV Technologies) is a biopharmaceutical company which develops self-administered and non-invasive therapies to treat food allergies and other immunological diseases. Its product pipeline includes Viaskin peanut, Viaskin milk and Viaskin egg indicated for the treatment o …
  • Bank Muscat:企業の戦略・SWOT・財務分析
    Bank Muscat - Strategy, SWOT and Corporate Finance Report Summary Bank Muscat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen), formerly Svenska Capital Oil AB is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It offers de …
  • Vanderbilt University Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center’s services include adult emergency services, case management, corporate health services, adult psychiat …
  • Hurtigruten AS:企業の戦略・SWOT・財務情報
    Hurtigruten AS - Strategy, SWOT and Corporate Finance Report Summary Hurtigruten AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bank of China Ltd:企業のM&A・事業提携・投資動向
    Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Cosmax Inc.:企業の戦略・SWOT・財務情報
    Cosmax Inc. - Strategy, SWOT and Corporate Finance Report Summary Cosmax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Drax Group Plc:企業の発電所・SWOT分析2018
    Drax Group Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • DCC plc (DCC):企業の財務・戦略的SWOT分析
    DCC plc (DCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Prologis, Inc.:企業の戦略・SWOT・財務情報
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aspen Technology, Inc. (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology, Inc. (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Murphy Oil Corporation:企業の戦略・SWOT・財務情報
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Kongsberg Maritime AS-石油・ガス分野:企業M&A・提携分析
    Summary Kongsberg Maritime AS (Kongsberg Maritime), a subsidiary of Kongsberg Gruppen AS, is a provider of merchant marine, subsea and offshore solutions. The company offers a wide range of products that include bridge systems, camera systems, deck systems, engine room and automation systems, inform …
  • Avisa Pharma Inc-医療機器分野:企業M&A・提携分析
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company’s product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; …
  • IHI Corp (7013):企業の財務・戦略的SWOT分析
    IHI Corp (7013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆